CHRONIC HEPATITIS B VIRUS INFECTION
Clinical trials for CHRONIC HEPATITIS B VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B VIRUS INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to clear hepatitis b in HIV patients
Disease control OngoingThis study tests a new drug called bepirovirsen in 153 people who have both HIV and chronic hepatitis B and are already on HIV treatment. The goal is to see if bepirovirsen can clear the hepatitis B virus from the body better than a placebo. Participants will continue their regul…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Two-Drug combo aims to cure chronic hepatitis b
Disease control OngoingThis study tests whether giving two experimental drugs in sequence can achieve a functional cure for chronic hepatitis B. Participants are adults with chronic HBV who are already on standard antiviral therapy. They will receive either one of two doses of daplusiran/tomligisiran f…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail shows promise for liver cancer in hepatitis b patients
Disease control OngoingThis study tests a combination of two drugs, atezolizumab and bevacizumab, in 51 people with advanced liver cancer who also have chronic hepatitis B. The goal is to see if the treatment can shrink tumors and control the disease. Participants receive the drugs every three weeks, a…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: NA • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo aims to clear hepatitis b virus in 86-Patient trial
Disease control OngoingThis phase 2 study tests whether adding the experimental drug BRII-835 to standard pegylated interferon can help people with chronic hepatitis B lose the virus surface antigen (HBsAg), a key marker of infection. Eighty-six adults on stable antiviral therapy will receive either in…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: PHASE2 • Sponsor: Brii Biosciences Limited • Aim: Disease control
Last updated Jun 26, 2026 13:27 UTC
-
New blood test could spot liver cancer sooner
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether a new blood test score, called GAAD, can detect liver cancer earlier in people with chronic liver disease. The GAAD score combines a person's gender, age, and two blood markers (AFP and PIVKA-II). Researchers will compare the GAAD score to standard u…
Matched conditions: CHRONIC HEPATITIS B VIRUS INFECTION
Phase: NA • Sponsor: Mahidol University • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC